Pacific Biosciences (PACB) Stock Price, Quote & News

Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonuclea...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 521 8000

Fax: 650 618 2699

Website: www.pacb.com

Address:

1305 O’Brien Drive, Menlo Park, United States

WallStreetWoof Jul. 29 at 7:54 PM

$PACB FOCL has held up better than PACB against the QQQ decline, and has actually moved up. I am thinking it will hit $10 by December.

0 · Reply

WolfyPuppyWolf Jul. 29 at 12:45 AM

$PACB 48,500 shares for me. I want to buy more but don't quite dare. I think it looks like it has still held up well against the $QQQ decline.

1 · Reply

FinanceCorp Jul. 28 at 1:29 PM

$PACB this is still a piece of💩 but I feel it’s about to explode to the upside

0 · Reply

TedsRocks Jul. 28 at 5:11 AM

$PACB Almost 1 week until Q2 earnings.

0 · Reply

WallStreetWoof Jul. 28 at 2:27 AM

$PACB Does EDAP/Focaltherics still receive any licensing revenus from Theraclion SA for the Echopulse ? Or has this partnership ended ?

0 · Reply

StockConsultant Jul. 24 at 1:27 PM

$PACB Pacific Biosciences of California stock watch, attempting to rally off the 1.35 triple+ support area at https://stockconsultant.com/?PACB Long Trade Target 1: 1.71 Profit: 22.1% Stop/Trailing Stop: 1.34 Loss: 4.3% P/L ratio: 5.1 : 1 - Excellent Target 2: 1.81 Profit: 29.3% P/L ratio: 6.8 : 1 - Excellent Extreme rally BULLISH [Positioning] Short term typical pullback, pullback may start to slow. [Positioning] at support [Timing] Mild bullish 3 day candlestick pattern with Strong 3 day accumulation. [Timing] Strong bullish 1 day moneyflow BEARISH [Positioning] Intermediate trend possibly bearish, Sideways trend near upper resistance.

0 · Reply

TedsRocks Jul. 23 at 2:39 AM

$PACB Great summary of PACB and Ark’s position discussed in Ark’s Q2 2026 webinar. Starting at approximately 28 minutes into the video. https://www.ark-funds.com/webinars/q2-2026-fund-webinar

0 · Reply

selftaught Jul. 22 at 2:31 PM

$PACB Would like to see a close above the 50dma

0 · Reply

WallStreetWoof Jul. 21 at 10:05 PM

$PACB A year ago I invested in both FOCL and PACB. I thought PACB was the better investment at the time, but FOCL hit an inflection point and has pretty much been on a steady climb over the last year. As it turned out, FOCL went from 1.5 to 5.5 in a year. PACB pretty much flat over the same time frame. FOCL will turn profitable in 2028 per executives....

0 · Reply

Razor_Ramon Jul. 21 at 3:46 PM

$PACB Sales better pick up 2nd half. Launch of SPRQ nx for Vega well before start of 4th quarter. Then, it's a race of do or dilution. Nothing else matters.

0 · Reply

PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference

Jul 15, 2026, 4:05 PM EDT - 14 days ago

PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026

Jun 18, 2026, 11:00 AM EDT - 5 weeks ago

Pacific Biosciences of California Transcript: Status update

Jun 4, 2026, 2:00 PM EDT - 7 weeks ago

Pacific Biosciences of California Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 12:00 PM EDT - 2 months ago

Pacific Biosciences of California Transcript: AGM 2026

2026-05-26T13:35:56.000Z - 2 months ago

PacBio announces SPRQ-Nx chemistry now shipping worldwide

May 26, 2026, 9:05 AM EDT - 2 months ago

PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing

May 22, 2026, 8:00 AM EDT - 2 months ago

Pacific Biosciences of California Proxy statement: Proxy filing

May 21, 2026, 4:05 PM EDT - 2 months ago

PacBio to Participate in the Jefferies Global Healthcare Conference

May 19, 2026, 9:00 AM EDT - 2 months ago

Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

May 11, 2026, 9:05 AM EDT - 2 months ago

HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

2026-05-11T10:14:51.000Z - 2 months ago

PacBio price target raised to $1.50 from $1 at Barclays

2026-05-07T22:16:25.000Z - 2 months ago

PacBio sees FY26 revenue $165M-$175M, consensus $174.42M

May 7, 2026, 4:30 PM EDT - 2 months ago

Pacific Biosciences of California Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Pacific Biosciences of California Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Pacific Biosciences of California Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Pacific Biosciences of California Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 2 months ago

PacBio Announces First Quarter 2026 Financial Results

Apr 23, 2026, 8:00 AM EDT - 3 months ago

Pacific Biosciences of California Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 3 months ago

Pacific Biosciences of California Proxy statement: Proxy filing

2026-04-21T15:03:16.000Z - 3 months ago

PacBio, Lucid Genomics announces collaboration to advance tertiary analysis

Apr 21, 2026, 9:05 AM EDT - 3 months ago

PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

Apr 16, 2026, 4:05 PM EDT - 3 months ago

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 15, 2026, 9:05 AM EDT - 3 months ago

PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

2026-04-14T10:47:16.000Z - 3 months ago

PacBio price target lowered to $1 from $1.50 at Barclays

2026-03-18T13:10:45.000Z - 4 months ago

PacBio HiFi selected by Basecamp Research AI lab

Mar 18, 2026, 9:05 AM EDT - 4 months ago

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

2026-03-06T11:31:43.000Z - 5 months ago

PacBio downgraded to Underweight from Equal Weight at Barclays

2026-03-06T11:11:00.000Z - 5 months ago

PacBio downgraded to Underweight from Equal Weight at Barclays

2026-03-05T13:44:59.000Z - 5 months ago

PacBio appoints Gibson to Board of Directors

RXRX

Mar 5, 2026, 8:30 AM EST - 5 months ago

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

Mar 2, 2026, 2:30 PM EST - 5 months ago

Pacific Biosciences of California Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-25T22:11:20.000Z - 5 months ago

PacBio files automatic mixed securities shelf

2026-02-24T14:11:12.000Z - 5 months ago

PacBio, DNAstack launhces global federated HiFi whole genome dataset

Feb 24, 2026, 9:05 AM EST - 5 months ago